AKBA - Akebia Therapeutics, Inc.

QQQ $ 480.19 $ -1.11 (-0.23 %)

DIA $ 408.63 $ -0.26 (-0.06 %)

SPY $ 558.92 $ -0.24 (-0.04 %)

TLT $ 98.40 $ 0.10 (0.1 %)

GLD $ 233.28 $ -0.44 (-0.19 %)

Previous Close

$ 1.49

Open

$ 1.49

Bid

$ 1.46 x 300

Ask

$ 1.47 x 1,892

Day's Range

$ 1.47 - $ 1.51

52 Week Range

$ 0.78 - $ 2.48

Volume

1,833,791

Average Volume

Market Cap

312.46M

Beta (5Y Monthly)

$ 1.47

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	03-14-2024	12-31-2023	10-K
4	11-08-2023	09-30-2023	10-Q
5	08-28-2023	06-30-2023	10-Q
6	05-08-2023	03-31-2023	10-Q
7	03-10-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-09-2022	03-31-2022	10-Q
11	03-01-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-10-2021	03-31-2021	10-Q
15	02-25-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-10-2020	06-30-2020	10-Q
18	05-05-2020	03-31-2020	10-Q
19	03-12-2020	12-31-2019	10-K
20	11-12-2019	09-30-2019	10-Q
21	08-08-2019	06-30-2019	10-Q
22	05-09-2019	03-31-2019	10-Q
23	03-26-2019	12-31-2018	10-K
24	11-08-2018	09-30-2018	10-Q
25	08-08-2018	06-30-2018	10-Q
26	05-09-2018	03-31-2018	10-Q
27	03-12-2018	12-31-2017	10-K
28	11-08-2017	09-30-2017	10-Q
29	08-08-2017	06-30-2017	10-Q
30	05-09-2017	03-31-2017	10-Q
31	03-06-2017	12-31-2016	10-K
32	11-09-2016	09-30-2016	10-Q
33	08-08-2016	06-30-2016	10-Q
34	05-05-2016	03-31-2016	10-Q
35	03-14-2016	12-31-2015	10-K
36	11-09-2015	09-30-2015	10-Q
37	08-11-2015	06-30-2015	10-Q
38	05-11-2015	03-31-2015	10-Q
39	03-04-2015	12-31-2014	10-K
40	11-10-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Maintains Buy on Akebi...
08/12/2024 11:06:37

HC Wainwright & Co. analyst Ed Arce maintains Akebia Therapeutics (NASDAQ:AKBA) with a Buy and raises the price target f...

Akebia Therapeutics Q2 2024 GAAP EPS $(0.0...
08/08/2024 11:16:07

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $...

Akebia And CSL Vifor Have Terminated The L...
07/11/2024 10:04:24

Under the terms of the agreement, CSL Vifor is entitled to quarterly tiered royalty payments ranging from a high single-digit...

Akebia Therapeutics Announced Erik Ostrows...
06/24/2024 13:00:45

Akebia Therapeutics Q1 2024 GAAP EPS $(0.0...
05/09/2024 11:04:36

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of...

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
04/10/2024 12:09:34

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
03/29/2024 16:30:53

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
03/28/2024 17:35:26

HC Wainwright & Co. Maintains Buy on Akebi...
03/28/2024 16:20:48

HC Wainwright & Co. analyst Ed Arce maintains Akebia Therapeutics (NASDAQ:AKBA) with a Buy and raises the price target f...

fda-approves-for-akebia-therapeutics-vafseo-for-kidney-disease-associated-anemia

FDA Approves For Akebia Therapeutics' Vafs...
03/28/2024 13:50:08

The FDA-approved Vafseo tablets by Akebia Therapeutics for managing anemia in adult dialysis patients with chronic kidney disea...

why-rh-shares-are-trading-higher-by-around-9-here-are-20-stocks-moving-premarket

Why RH Shares Are Trading Higher By Around...
03/28/2024 12:21:31

Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results.

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
03/28/2024 12:06:10

Akebia Therapeutics shares are trading hig...
03/28/2024 11:24:19

Reported Earlier, Akebia's Wins FDA Approv...
03/28/2024 05:51:37

Once-Daily Oral HIF-PH Inhibitor Activates Physiologic Response to Manage Anemia Akebia's Launch Strategy Developed to ...

Cintas Reports Upbeat Earnings, Joins PayS...
03/27/2024 14:03:27

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.

why-westport-fuel-systems-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Westport Fuel Systems Shares Are Tradi...
03/26/2024 17:45:27

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected ...

12 Health Care Stocks Moving In Friday's I...
03/15/2024 17:31:09

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
03/15/2024 13:06:20

HC Wainwright & Co. Reiterates Buy on Akeb...
03/15/2024 10:27:15

HC Wainwright & Co. analyst Ed Arce reiterates Akebia Therapeutics (NASDAQ:AKBA) with a Buy and maintains $5 price target.

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
03/14/2024 21:33:37